Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Shelley Butler

1PUBLICATIONS

19CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Oct 30, 2025

Preclinical Development of MGC028, an ADAM9-Targeted, Glycan-Linked, Exatecan-Based Antibody-Drug Conjugate for the Treatment of Solid Cancers.

Juniper A Scribner, Jennifer G Brown, Thomas Son

Pageof 1

Frequent Collaborators

1 joint publications

Juniper A Scribner

1 joint publications

Jennifer G Brown

1 joint publications

Thomas Son

1 joint publications

Linda Jin

1 joint publications

Carroll McKenzie

1 joint publications

Viktoriya Nam

1 joint publications

Curtis Bush

1 joint publications

Dienis Quinonez

1 joint publications

Delta Ford

1 joint publications

James Tamura

Frequent Collaborators

1 joint publications

Juniper A Scribner

1 joint publications

Jennifer G Brown

1 joint publications

Thomas Son

1 joint publications

Linda Jin

Top Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

See more related videos

Top Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

See more related videos